We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This consultation seeks views on amending the Human Medicines Regulations 2012 to support the ongoing supply and deployment of vaccinations across the UK.
This is the original consultation document. Executive summary In response…
Introduction In response to the COVID-19 pandemic, multiple regulations…
This consultation aims to seek views on the possible introduction of regulations mandating the disclosure of industry payments to the healthcare sector.
Ministerial foreword This consultation comes at an important time for the…
References to ‘government’ in this document relate to the UK government in…
The MHRA is seeking evidence on the regulation of AI in healthcare to inform the recommendations of the National Commission into the Regulation of AI in Healthcare.
This section contains information which may be helpful background when…
How AI is being used in healthcare Artificial intelligence (AI) is being…
Consultation seeking views on proposals to give ministers limited powers to direct the National Institute for Health and Care Excellence (NICE) in setting the standard cost-effectiveness threshold.
The MHRA invites health institutions in Great Britain to share their experience of the health institution exemption (sometimes referred to as an in-house manufacturing exemption).
The MHRA is consulting with UK stakeholders to gather feedback and comments on an international guideline on the assessment and control of extractables and leachables.
A paper outlining MHRA’s intentions to make it quicker and easier to get rare disease therapies tested, manufactured and approved in the UK.
Proposal to make a permanent order to prevent new patients aged under 18 from beginning to take puberty blockers for the purposes of gender incongruence and/or gender dysphoria, under the care of private prescribers.
We are seeking feedback on our new draft guideline on individualised mRNA cancer immunotherapies, a new type of cancer treatment being tested in clinical trials. This will help us to clarify and streamline pathways for bring…
This report provides an update on activities during the first year of the UK 5-year national action plan for antimicrobial resistance 2024 to 2029.
This consultation seeks views on proposals to enable pharmacist flexibilities when dispensing medicines.
The MHRA invite feedback on the use of designated standards for medical devices and in vitro diagnostic (IVD) devices to help shape future initiatives.
Seeks views on extending the range of medicines available to optometrists and contact lens opticians so they can treat minor eye conditions in the community.
Consultation on proposals to update the MHRA's statutory fees to ensure they continue to recover their costs.
DHSC and NHS England’s ongoing work and future plans to improve shortage management and strengthen medicines supply chain resilience.
This call for evidence seeks views on how the current system operates in relation to patient access to medicines through private (non-NHS) routes.
The MHRA is consulting with UK stakeholders to gather feedback and comments on a revised international guideline, M4Q(R2).
We are seeking your views on what procedures should be in scope of the licensing scheme for non-surgical cosmetic procedures in England.
This consultation seeks views on extending medicines responsibilities for paramedics, physiotherapists, operating department practitioners and diagnostic radiographers.
An update on progress the government has made to go beyond implementing the Lord O'Shaughnessy review of commercial clinical trials and how it is going further and faster to transform the UK clinical research system.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).